Our aim is to achieve respiratory disease modification & cure. To unlock new pathways, we are exploring advancements in #biotechnology. We believe that drug modalities like oligonucleotides allow us to target the underlying causes of #asthma. bit.ly/2NaQ9c3 #ERSCongress

Exciting times!

To reach our goal of modifying & ultimately curing #respiratory disease, we need to be able to address targets previously seen as inaccessible. Maria Belvisi, Vice President and Head, RIA Innovative Medicines, explains how we're doing this: bit.ly/2DiAiUf. #ERSCongress

Allergen challenge increases capsaicin evoked cough responses in allergic asthma. dlvr.it/Qx87SY

Very excited to have Peter joining us a Chief Scientist in our Respiratory group Maria Belvisi AstraZeneca

⁦HSBC Championships⁩

⁦Maria Belvisi⁩ Tim Eisen attended the ⁦Academy of Medical Sciences⁩ ceremony for new fellows yesterday. Great honour to be elected.

Read about how ⁦⁦⁦AstraZeneca⁩ are participating in collaborations to treat COVID-19 patients #covid-19 #research #proudpartner #joiningforces businessweekly.co.uk/news/biomedtec…

Bonvini and co-workers employ a creative combination of cell, tissue and in vivo models to delineate a complex intercellular communication between mast cells and airway smooth muscle by which TRPV4 activation causes bronchoconstriction bit.ly/35U4Mqg

PAIN mechanisms: new role for a sodium channel NaV1.1. on peripheral nerve fibres. buff.ly/29RelLd Latest report

CNS Summit #cnssummit Mike Rea, IDEA Pharma Top 10 most innovative pharma companies this year in digital tech, partnerships, and trial optimization.

A Functional Kinase Short Interfering Ribonucleic Acid Screen Using Protease-Activated Receptor 2-Dependent Opening of Transient Receptor Potential Vanilloid-4. dlvr.it/Q1bLfb

Airway expression of Transient Receptor Potential (TRP) Vanniloid-1 and Ankyrin-1 channels is not increased in patients with Idiopathic Pulmonary Fibrosis. dlvr.it/Q1bLg9

ROGER #nittoatptourfinals

New research collaboration between Imperial and AstraZenecaUK will focus on respiratory mechanisms related to inflammation and lung irritancy ow.ly/qetJ30homu1

. Imperial College London partners with AstraZeneca to investigate drivers of #respiratory disease ow.ly/9rTL30hoowu - with Profs Belvisi & Tetley and Dr Birrell.

#RotterdamOpen #abnamrowwtt #worldnumber1 #KingRoger

Sir Mark Walport said British and EU scientists should be able to live and work freely across Europe. “In any good lab you will find researchers from all over the world,” thetimes.co.uk/article/scient…

Sad day..Tessa Jowell RIP. x.com/copddoc/status…

One week left to register for Current trends in drug discovery (7 June). Hear 3 internationally recognised speakers – including Maria Belvisi of AstraZeneca talk abouton discovering new therapeutic options for chronic respiratory disease. buff.ly/2w3FPL1